Skip to main content

Romesh Subramanian

Equibles does not estimate personal net worth.

About Romesh Subramanian

Dyne Therapeutics, Inc. reported in an 8-K filed June 2, 2021 that Romesh Subramanian resigned as Chief Scientific Officer, effective June 2, 2021. The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $4,370,975 for Romesh Subramanian in fiscal 2020, including a base salary of $371,875. Disclosed compensation is on record for 2 fiscal years.

“On May 27, 2021, Romesh Subramanian, Ph.D., the Chief Scientific Officer of Dyne Therapeutics, Inc. (the “Company”), notified the Company that he planned to resign his employment with the Company effective June 2, 2021 (the “Resignation Date”).”
Dyne Therapeutics, Inc. Form 8-K, filed June 2, 2021 · Read the filing

Affiliation history

Company network

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Dyne Therapeutics, Inc. (DYN) $371,875 $4,370,975
2019 Dyne Therapeutics, Inc. (DYN) $350,002 $411,660

Recent activity